Plant Comparison

Goldenseal vs Clove

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AGoldensealHydrastis canadensisRanunculaceaeFull monograph →
Plant BCloveSyzygium aromaticumMyrtaceaeFull monograph →

At a glance

Goldenseal and Clove: they share 7 indicated uses (arthritis / joint pain, bloating, indigestion, …); 3 pharmacological actions in common.

GoldensealClove
Constituents13
Pharmacological actions46
Indicated uses912
Safety notes22
Cited sources2014
Indicated uses
Only Goldenseal
DiarrhoeaSore throat
Shared (7)
Arthritis / joint painBloatingIndigestionInfection (general)Inflammation (general)Skin irritationWounds
Only Clove
Back painCancer (anticancer research)HeadacheOral & throat healthPain (general)
Pharmacological actions
Only Goldenseal
Astringent
Shared (3)
Anti-inflammatoryAntimicrobialDigestive aid
Only Clove
Analgesic (pain relief)Anticancer (preclinical)Antioxidant

Evidence face-off — shared uses

ConditionGoldensealCloveVerdict
Arthritis / joint pain5/102/10Stronger for Goldenseal
Bloating5/101/10Stronger for Goldenseal
Indigestion5/101/10Stronger for Goldenseal
Infection (general)5/102/10Stronger for Goldenseal
Inflammation (general)5/101/10Stronger for Goldenseal
Skin irritation5/101/10Stronger for Goldenseal
Wounds5/101/10Stronger for Goldenseal

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Isoquinoline alkaloids - berberine (principal), hydrastine and canadine[1, 4, 12]

Berberine is the main antimicrobial, hypoglycaemic and hypolipidaemic constituent. Notably, whole-leaf extracts are more potent against MRSA than isolated berberine (owing to efflux-pump-inhibitory flavonoids) and show quorum-quenching, anti-virulence activity.

FlavonoidsAlkaloidsBerberine
Essential oil (eugenol)[1, 2]

Eugenol typically makes up the great majority of clove oil and is responsible for most of its analgesic, antimicrobial and anti-inflammatory activity.

Essential (volatile) oilEugenol
Flavonoids and phenolic acids[3]

Contribute additional antioxidant activity.

FlavonoidsPhenolic acids
Tannins[2]

Contribute mild astringency.

Tannins

Pharmacological Actions

Anti-inflammatory[1]

Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)

Antimicrobial[1, 2, 3, 4, 5, 6, 12]

Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat

Astringent[1]

Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)

Digestive aid[1, 5]

Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)

Analgesic (pain relief)[2, 11, 12, 13]
Anti-inflammatory[2, 3, 8, 11, 12, 13]
Anticancer (preclinical)[10]
Antimicrobial[1, 2, 3, 5, 7, 11, 12, 13]
Antioxidant[1, 2, 4, 6, 7, 11, 12, 13]
Digestive aid[9, 11, 12, 13]

Traditional & Indicated Uses

Arthritis / joint pain[1]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Arthritis / joint pain
Bloating[1]Moderate · 5/10

inferred from digestive action

Evidence: 5
Label: Bloating
Diarrhoea[1]Moderate · 5/10

inferred from astringent action

Evidence: 5
Label: Diarrhoea
Indigestion[1]Moderate · 5/10

Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)

Evidence: 5
Label: Indigestion
Infection (general)[1, 4, 12]Moderate · 5/10

Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat; Topical for skin infections and irritation - whole-leaf extract is active in vitro against methicillin-resistant Staphylococcus aureus (MRSA)

Evidence: 5
Label: Infection (general)
Inflammation (general)[1]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Inflammation (general)
Skin irritation[1]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Skin irritation
Sore throat[1, 4, 12]Moderate · 5/10

Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth); Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat

Evidence: 5
Label: Sore throat
Wounds[1, 4, 12]Moderate · 5/10

inferred from antimicrobial action

Evidence: 5
Label: Wounds
Arthritis / joint pain[8, 11, 12, 13]Traditional · 2/10

inferred from anti-inflammatory action

Evidence: 2
Label: Arthritis / joint pain
Back pain[11, 12, 13]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Back pain
Bloating[11, 12, 13]Traditional · 1/10

inferred from digestive action

Evidence: 1
Label: Bloating
Cancer (anticancer research)[10]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Headache[11, 12, 13]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Headache
Indigestion[11, 12, 13]Traditional · 1/10

inferred from digestive action

Evidence: 1
Label: Indigestion
Infection (general)[5, 11, 12, 13]Traditional · 2/10

inferred from antimicrobial action

Evidence: 2
Label: Infection (general)
Inflammation (general)[11, 12, 13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Oral & throat health[11, 12, 13]Traditional · 1/10
Evidence: 1
Label: Oral & throat health
Pain (general)[11, 12, 13]Traditional · 1/10
Evidence: 1
Label: Pain (general)
Skin irritation[11, 12, 13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[11, 12, 13]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds

Safety, Cautions & Contraindications

Safety note[1]Caution

Contraindicated in pregnancy and breastfeeding: berberine crosses the placenta and into milk and can cause or worsen newborn jaundice (risk of kernicterus); do not give to infants.

Safety note[1, 14]Caution

Berberine strongly inhibits drug-metabolising enzymes (especially CYP3A4 and CYP2D6), so it can raise the blood levels of many medicines - a significant herb-drug-interaction risk. In a screen of commercial herbal products, goldenseal was among the most potent CYP2D6 inhibitors and also inhibited CYP3A4. High doses have shown possible liver, nerve and photo-toxicity.

Safety note[11, 12, 13]Caution

Strong and concentrated: Clove oil is very potent and should always be diluted before skin or mouth use.Dental use: Undiluted clove oil can burn gums or skin.Blood thinning: Clove may increase bleeding risk in large amounts or with anticoagulants.Pregnancy: Culinary amounts are fine; medicinal doses should be used cautiously.Children: Essential oil should be used with extra caution and diluted well.

Safety note[11, 12, 13, 14]Caution

Duke (2002) rates cloves as +++ with clinical evidence (score 2) for analgesic activity — specifically, topical application of clove oil (eugenol) for dental pain is clinically validated. The plant also shows strong antimicrobial, antifungal (anti-Candida), antispasmodic, and antiviral activities at the experimental level. Commission E approves topical clove preparations for dental pain. Recommended dose: 1–5% clove oil preparation (topical) or 150 mg clove powder internally. The essential oil is irritating to mucous membranes and should not be applied undiluted to skin or mucous membranes (Duke, 2002).

External Ids

Gbif: 3033110
Wikidata: Q1051710
Gbif: 3183002
Wikidata: Q26736

Botanical Description

Low, woodland perennial herb rising from a knotted, bright yellow rhizome with wiry yellow roots. Each stem bears two ragged, palmately lobed, maple-like leaves and a single small, inconspicuous greenish-white flower, followed by a raspberry-like cluster of red berries.[1]

Height: 15-30 cm
Habit: Low, woodland perennial herb
Leaves: Two per stem, ragged, palmately lobed, maple-like
Flowers: Single, small, inconspicuous, greenish-white, petal-less
Stem: Hairy, upright, bearing two leaves
Root: Knotted, bright yellow rhizome with wiry yellow roots (the medicinal part)
Fruit: Raspberry-like cluster of red berries
Flowering Period: April-May

Evergreen tree (Myrtaceae), 8-12 m tall (occasionally to 20 m), with a pyramidal crown. Leaves are glossy, elliptical and aromatic. Small crimson flowers are borne in terminal clusters; the unopened flower buds, picked before they open and dried, are the 'cloves' of commerce and the medicinal/culinary part used.[2]

Height: 8-12 m (occasionally to 20 m)
Habit: Evergreen tree with a pyramidal crown
Leaves: Glossy, elliptical, aromatic
Flowers: Small, crimson, in terminal clusters; unopened buds are the harvested cloves
Stem: Woody, branching
Root: Deep woody root system
Fruit: Small drupe ("mother clove"), less commonly harvested than the flower bud
Flowering Period: Variable, often twice a year in tropical climates

Habitat

Grows in rich, shaded deciduous woodland with humus-rich soil; native to eastern North America, now scarce in the wild due to overharvesting and largely supplied by cultivation.[1]

Native to the Maluku Islands (Moluccas, the historic 'Spice Islands') of Indonesia, now cultivated throughout the tropics, notably Zanzibar, Madagascar, Sri Lanka and Indonesia, in warm, humid, well-drained tropical conditions.[2]

Harvesting

The rhizome and root are dug in autumn from plants at least three to four years old, when berberine content is highest, then cleaned and dried; because wild populations are depleted, cultivated or sustainably sourced material is strongly preferred, and careful identification against the toxic mayapple and bloodroot, which share its woodland habitat, is essential before any wild-harvesting.[1]

Parts: Rhizome and root
Season: Autumn, from mature (3-4+ year) plants

Unopened flower buds are hand-picked while still green-pink, just before they would open, then sun-dried until they turn dark reddish-brown - the familiar clove spice.[2]

Parts: Flower
Season: Before the flower buds open

Traditional Uses

Goldenseal root has a Native American and, after adoption by Eclectic physicians, wider North American tradition as a bitter tonic and antimicrobial remedy for mucous-membrane infections, sore throat, digestive upset and topical skin infections, directly reflecting its high berberine content.[1]

Clove has an ancient trade history and a long traditional use across Asian, African and European medicine as a dental analgesic (chewed or applied as oil for toothache), a digestive carminative, and an antiseptic. Modern research on its principal constituent eugenol supports strong analgesic, antimicrobial, antioxidant and anti-inflammatory activity, with clove oil remaining a recognised topical dental-pain remedy.[2]

Preparations

Decoction[1]

Dried rhizome and root simmered in water as a traditional bitter antimicrobial tea, or used as a gargle for sore throat.

Tincture[13]

Tincture 1:10 in 60% ethanol of the dried rhizome and root, 2-4 ml three times daily per the WHO monograph Rhizoma Hydrastis. Educational reference only, not a prescription.

Standardised extract[4]

Extract standardised to berberine/hydrastine content, taken as capsules; whole-leaf extracts have shown stronger antimicrobial activity than isolated berberine in some studies.

Whole clove (culinary/chewed)[2]

Whole dried flower buds chewed or infused for digestive and dental use.

Clove oil (topical, diluted)[11, 12, 13]

The classic dental-pain remedy, applied to the affected tooth/gum, always diluted.

Dosage

Decoction/tincture[13]

The WHO monograph on Rhizoma Hydrastis gives a daily dose of 0.5-1.0 g of the dried rhizome and root three times, or taken as a decoction; a 1:1 liquid extract in 60% ethanol at 0.3-1.0 mL three times; or a 1:10 tincture in 60% ethanol at 2-4 mL three times. For short-term use only, given goldenseal's potent CYP-enzyme inhibition and its contraindication in pregnancy. Educational reference only, not a prescription.

Clove oil / powder[11, 12, 13]

Duke (2002): a 1-5% clove oil preparation topically, or about 150 mg clove powder internally. Educational reference only, not a prescription; never apply undiluted oil to skin or mucous membranes.

References

REF-0455, REF-1849, REF-1850, REF-0588, REF-1851, REF-1852, REF-1853, REF-1854, REF-1855, REF-1856, REF-1857
REF-1074, REF-1075, REF-1076, REF-1077, REF-1078, REF-1079, REF-1080, REF-1081, REF-1082, REF-1083

Drug Class Interactions

Safety note[15, 16]Caution
Drug Class: cyp3a4-substrates
Mechanism: Goldenseal's berberine and hydrastine strongly inhibit CYP3A4 (and also CYP2D6), enzymes that clear many medicines. In a controlled study in healthy volunteers, 28 days of goldenseal cut CYP3A4/5 and CYP2D6 activity by roughly 40%, so it can raise the blood levels and side effects of drugs handled by these pathways - for example some statins, calcium-channel blockers and sedatives (CYP3A4), and certain antidepressants, beta-blockers and opioids (CYP2D6). Separate dosing and monitor, or avoid combining with narrow-margin medicines.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[17]Caution
Drug Class: antidiabetics
Mechanism: Goldenseal is rich in berberine, its main alkaloid, which lowers blood glucose - meta-analyses of randomised trials show berberine significantly reduces fasting glucose and HbA1c. Taken with diabetes medicines, goldenseal may therefore add to blood-sugar lowering, so monitor blood glucose.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Not documented

Lookalikes Review

Outcome: has-lookalikes
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Dangerous Lookalikes

Safety note[18, 19]Dangerous
Dangerous Plant: podophyllum-peltatum
Confused Part: Woodland rhizome dug as goldenseal; mayapple shares the same rich woods and has similar lobed, maple-like leaves.
Confusion Context: Goldenseal (Hydrastis canadensis) is dug from rich woodland for its yellow rhizome. Mayapple (Podophyllum peltatum) grows in the same rich-woods habitat and, once its leaves expand, its lobed maple-like leaves resemble goldenseal, so novice foragers confuse them. Mayapple contains podophyllotoxin (a potent cell poison) in all parts except the ripe fruit; ingestion causes severe vomiting and diarrhoea and can cause serious systemic toxicity. Because the plants share habitat and leaf shape, this is a genuine hazard when digging goldenseal.
Distinguishing Features: Whole plant: goldenseal has a hairy upright stem bearing usually two ragged, maple-like lobed leaves and a single small flower, with a knotted BRIGHT-YELLOW rhizome. Mayapple has one or two large, smooth, umbrella-like lobed leaves on a hairless stalk and a white flower nodding beneath, with a white-ish creeping rhizome., Rhizome colour (decisive): goldenseal's rhizome and root are vivid yellow inside (berberine). Mayapple's rhizome is not bright yellow., Leaf texture: goldenseal leaves are hairy and puckered; mayapple leaves are large, smooth and shield-like (the stalk joins near the centre).
Key Test: Dig only after matching the whole plant, and check the rhizome. A hairy stem with ragged maple-like leaves over a BRIGHT-YELLOW knotted rhizome = goldenseal. Large smooth umbrella-like leaves over a pale rhizome (no yellow) = mayapple - toxic, do not use. If the root is not bright yellow inside, do not use it.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Safety note[18, 20]Dangerous
Dangerous Plant: sanguinaria-canadensis
Confused Part: Woodland rhizome dug as goldenseal; bloodroot grows in the same rich woods and its rhizome is gathered in mistake for goldenseal.
Confusion Context: Bloodroot (Sanguinaria canadensis) shares the same rich-woods spring habitat as goldenseal and is listed among goldenseal's harvesting look-alikes. Bloodroot is a high-severity poison: its rhizome contains isoquinoline alkaloids (sanguinarine) and, when broken, oozes a bright red-orange sap; ingestion causes vomiting, faintness, dizziness, dilated pupils and, in serious cases, heart failure, and the sap is destructive to tissue. Because both are dug for their rhizomes from the same woodland, this is a genuine hazard.
Distinguishing Features: Sap colour (decisive): a broken bloodroot rhizome bleeds a bright RED-ORANGE sap. Goldenseal's rhizome is BRIGHT YELLOW inside, not red., Leaf: bloodroot has a single, rounded, deeply scalloped/lobed grey-green leaf that wraps the flower stalk, and a white flower; goldenseal has a hairy stem with two ragged maple-like leaves., Whole plant: confirm goldenseal by its paired hairy maple-like leaves and yellow root before digging.
Key Test: Break the rhizome and look at the sap and leaves. Bright YELLOW root with paired hairy maple-like leaves = goldenseal. A single scalloped leaf and a rhizome bleeding RED-ORANGE sap = bloodroot - a high-severity poison, do not use. If the sap is red, it is not goldenseal.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Not documented

References & Sources

  1. Mandal, S.K., Maji, A.K., Mishra, S.K., Ishfaq, P.M., Devkota, H.P., Silva, A.S. and Das, N (2020) 'Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues', Pharmacological Research. doi:10.1016/j.phrs.2020.105085 Randomized trial
    https://doi.org/10.1016/j.phrs.2020.105085
  2. Corn, J., Tibbitts, D., Ito, H., Schafer, M. and Vasilevsky, N (2021) 'Effects of Hydrastis Canadensis, Commiphora Habessinica, Phytolacca Americana, and Echinacea Purpurea on Bacterial Growth', Alternative Therapies in Health and Medicine, 27(4), pp. 24-27. Preclinical
    https://scholar.google.com/scholar?q=Effects%20of%20Hydrastis%20Canadensis%2C%20Commiphora%20Habessinica%2C%20Phytolacca%20Americana%2C%20and%20Echinacea%20Purpurea%20on%20Bacterial%20Growth
  3. Ettefagh, K.A., Burns, J.T., Junio, H.A., Kaatz, G.W. and Cech, N.B (2010) 'Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition', Planta Medica, 77(8), pp. 835-840. doi:10.1055/s-0030-1250606 Preclinical
    https://doi.org/10.1055/s-0030-1250606
  4. Cech, N.B., Junio, H.A., Ackermann, L.W., Kavanaugh, J.S. and Horswill, A.R (2012) 'Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA)', Planta Medica, 78(14), pp. 1556--1561. doi:10.1055/s-0032-1315042 Traditional / reference
    https://doi.org/10.1055/s-0032-1315042
  5. Mahady, G.B., Pendland, S.L., Stoia, A. and Chadwick, L.R (2003) 'In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis', Phytotherapy Research, 17(3), pp. 217-221. doi:10.1002/ptr.1108 Preclinical
    https://doi.org/10.1002/ptr.1108
  6. Junio, H.A., Sy-Cordero, A.A., Ettefagh, K.A., Burns, J.T., Micko, K.T., Graf, T.N., Richter, S.J., Cannon, R.E., Oberlies, N.H. and Cech, N.B (2011) 'Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)', Journal of Natural Products, 74(7), pp. 1621-1629. doi:10.1021/np200336g Preclinical
    https://doi.org/10.1021/np200336g
  7. Britton, E.R., Kellogg, J.J., Kvalheim, O.M. and Cech, N.B (2017) 'Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal)', Journal of Natural Products, 81(3), pp. 484-493. doi:10.1021/acs.jnatprod.7b00654 Preclinical
    https://doi.org/10.1021/acs.jnatprod.7b00654
  8. Leyte-Lugo, M., Britton, E.R., Foil, D.H., Brown, A.R., Todd, D.A., Rivera-Chavez, J., Oberlies, N.H. and Cech, N.B (2017) 'Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis)', Phytochemistry Letters, 20, pp. 54-60. doi:10.1016/j.phytol.2017.03.012 Preclinical
    https://doi.org/10.1016/j.phytol.2017.03.012
  9. Gurley, B.J., Swain, A., Hubbard, M.A., Hartsfield, F., Thaden, J., Williams, D.K., Gentry, W.B. and Tong, Y (2007) 'Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo', Clinical Pharmacology and Therapeutics, 83(1), pp. 61-69. doi:10.1038/sj.clpt.6100222 Randomized trial
    https://doi.org/10.1038/sj.clpt.6100222
  10. Wallace, E.D., Oberlies, N.H., Cech, N.B. and Kellogg, J.J (2018) 'Detection of adulteration in Hydrastis canadensis (goldenseal) dietary supplements via untargeted mass spectrometry-based metabolomics', Food and Chemical Toxicology, 120, pp. 439-447. doi:10.1016/j.fct.2018.07.033 Preclinical
    https://doi.org/10.1016/j.fct.2018.07.033
  11. Douglas, J.A., Follett, J.M., Parmenter, G.A., Sansom, C.E., Perry, N.B. and Littler, R.A (2010) 'Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis', Fitoterapia, 81(7), pp. 925-928. doi:10.1016/j.fitote.2010.06.006 Preclinical
    https://doi.org/10.1016/j.fitote.2010.06.006
  12. Singh, S., Pathak, N., Fatima, E. and Negi, A.S (2021) 'Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine', European Journal of Medicinal Chemistry. doi:10.1016/j.ejmech.2021.113839 Preclinical
    https://doi.org/10.1016/j.ejmech.2021.113839
  13. World Health Organization (2007) 'Rhizoma Hydrastis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
    https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37
  14. Sevior, D.K., Hokkanen, J., Tolonen, A., Abass, K., Tursas, L., Pelkonen, O. and Ahokas, J.T (2010) 'Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail', Xenobiotica, 40(4), pp. 245--254. doi:10.3109/00498251003592683 Preclinical
    https://doi.org/10.3109/00498251003592683
  15. Gurley, B.J., Gardner, S.F., Hubbard, M.A., Williams, D.K., Gentry, W.B., Khan, I.A. and Shah, A (2005) 'In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes', Clinical Pharmacology and Therapeutics, 77(5), pp. 415-426. doi:10.1016/j.clpt.2005.01.009 Randomized trial
    https://doi.org/10.1016/j.clpt.2005.01.009
  16. McDonald, M.G., Tian, D.D., Thummel, K.E., Paine, M.F. and Rettie, A.E (2020) 'Modulation of major human liver microsomal cytochromes P450 by component alkaloids of goldenseal: time-dependent inhibition and allosteric effects', Drug Metabolism and Disposition, 48(10), pp. 1018-1027. doi:10.1124/dmd.120.091041 Preclinical
    https://doi.org/10.1124/dmd.120.091041
  17. Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., Zhang, C., Wang, Y. and Liu, W.J (2021) 'The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials', Oxidative Medicine and Cellular Longevity, 2021, pp. 2074610. doi:10.1155/2021/2074610 Meta-analysis / review
    https://doi.org/10.1155/2021/2074610
  18. Forest Farming (Cooperative Extension) 'Goldenseal (Hydrastis canadensis L.)'. Available at: https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ Traditional / reference
    https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/
  19. Frasca, T. and Brett, A.S. and Yoo, S.D (1997) 'Mandrake toxicity. A case of mistaken identity', Archives of Internal Medicine, 157(17), pp. 2007-9. doi:10.1001/archinte.157.17.2007 Clinical study
    https://doi.org/10.1001/archinte.157.17.2007
  20. North Carolina Extension Gardener Plant Toolbox 'Sanguinaria canadensis (Bloodroot)'. Available at: https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/ Traditional / reference
    https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/
  1. Haro-Gonzalez, J.N., Castillo-Herrera, G.A., Martinez-Velazquez, M. and Espinosa-Andrews, H (2021) 'Clove Essential Oil (Syzygium aromaticum L. Myrtaceae): Extraction, Chemical Composition, Food Applications, and Essential Bioactivity for Human Health', Molecules, 26(21), pp. 6387. doi:10.3390/molecules26216387 Meta-analysis / review
    https://doi.org/10.3390/molecules26216387
  2. Batiha, G.E., Alkazmi, L.M., Wasef, L.G., Beshbishy, A.M. and others (2020) 'Syzygium aromaticum L. (Myrtaceae): Traditional Uses, Bioactive Chemical Constituents, Pharmacological and Toxicological Activities', Biomolecules, 10(2), pp. 202. doi:10.3390/biom10020202 Meta-analysis / review
    https://doi.org/10.3390/biom10020202
  3. Vicidomini, C., Roviello, V. and Roviello, G.N (2021) 'Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility', Molecules, 26(7), pp. 1880. doi:10.3390/molecules26071880 Meta-analysis / review
    https://doi.org/10.3390/molecules26071880
  4. Irahal, I.N., Guenaou, I., Lahlou, F.A., Hmimid, F. and others (2022) 'Syzygium aromaticum bud (clove) essential oil is a novel and safe aldose reductase inhibitor: in silico, in vitro, and in vivo evidence', Hormones (Athens), 21(2), pp. 229-240. doi:10.1007/s42000-021-00347-6 Preclinical
    https://doi.org/10.1007/s42000-021-00347-6
  5. Yassin, M.T., Mostafa, A.A. and Al-Askar, A.A (2020) 'In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis', BMC Complementary Medicine and Therapies, 20(1), pp. 25. doi:10.1186/s12906-020-2818-8 Preclinical
    https://doi.org/10.1186/s12906-020-2818-8
  6. Kiki, M.J (2023) 'In Vitro Antiviral Potential, Antioxidant, and Chemical Composition of Clove (Syzygium aromaticum) Essential Oil', Molecules, 28(6), pp. 2421. doi:10.3390/molecules28062421 Preclinical
    https://doi.org/10.3390/molecules28062421
  7. Radunz, M., da Trindade, M.L.M., Camargo, T.M., Radunz, A.L. and others (2019) 'Antimicrobial and antioxidant activity of unencapsulated and encapsulated clove (Syzygium aromaticum, L.) essential oil', Food Chemistry, 276, pp. 180-186. doi:10.1016/j.foodchem.2018.09.173 Preclinical
    https://doi.org/10.1016/j.foodchem.2018.09.173
  8. Shakeel, F., Alam, P., Ali, A., Alqarni, M.H. and others (2021) 'Investigating Antiarthritic Potential of Nanostructured Clove Oil (Syzygium aromaticum) in FCA-Induced Arthritic Rats: Pharmaceutical Action and Delivery Strategies', Molecules, 26(23), pp. 7327. doi:10.3390/molecules26237327 Preclinical
    https://doi.org/10.3390/molecules26237327
  9. Tu, Z., Moss-Pierce, T., Ford, P. and Jiang, T.A (2014) 'Syzygium aromaticum L. (Clove) extract regulates energy metabolism in myocytes', Journal of Medicinal Food, 17(9), pp. 1003-1010. doi:10.1089/jmf.2013.0175 Preclinical
    https://doi.org/10.1089/jmf.2013.0175
  10. Banerjee, S., Panda, C.K. and Das, S (2006) 'Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer', Carcinogenesis, 27(8), pp. 1645-1654. doi:10.1093/carcin/bgi372 Preclinical
    https://doi.org/10.1093/carcin/bgi372
  11. Bhowmik, D., Kumar, K.P.S., Yadav, A., Srivastava, S., Paswan, S. and Dutta, A.S (2012) 'Recent trends in Indian traditional herbs Syzygium aromaticum and its health benefits', 1(1), pp. 13--23. Traditional / reference
    https://scholar.google.com/scholar?q=Recent%20trends%20in%20Indian%20traditional%20herbs%20Syzygium%20aromaticum%20and%20its%20health%20benefits
  12. Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
    https://powo.science.kew.org
  13. World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
    https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants
  14. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.